<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Department of Ophthalmology News and Stories


Education    Retina    Medical imaging

Employing Portable Fundus Photography Cameras to Enhance On-Call Imaging

Ophthalmology residents at the University of Colorado School of Medicine never know exactly what kind of eye or vision complaints will land in their care while on-call in a hospital, but they’re prepared for almost anything.

Author Kara Mason | Publish Date February 27, 2024
Full Story

Community    Pediatric Ophthalmology    Retina

Maintaining Healthy Eyes Throughout the Holidays

This time of year can bring lots of joy, but it can also lead to many hazards for ocular health, says Rebecca Edwards Mayhew, MD, PhD, assistant professor in the Department of Ophthalmology at the University of Colorado School of Medicine.

Author Kara Mason | Publish Date December 14, 2023
Full Story

Research    Retina   

CellSight Contributes Light-Sensitive Retinal Organoids and RPE Cells to New AMD Study

A partnership between ophthalmology researchers at the University of Colorado School of Medicine and Johns Hopkins University expands the understanding of how oxidative stress contributes to the development of choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD).

Author Kara Mason | Publish Date December 06, 2023
Full Story

Research    Plastic Surgery    Retina

What’s the Future of Eye Transplantation?

Doctors in New York this month announced the world’s first successful whole-eye and partial face transplant, a feat Kia Washington, MD, professor of plastic and reconstructive surgery at the University of Colorado School of Medicine, says sets the stage for further advancement in the field and shows promise that patients may one day regain vision after an eye transplant.

Author Kara Mason | Publish Date November 16, 2023
Full Story

Community    Retina

How to Protect Your Vision While Viewing a Solar Eclipse

During a solar eclipse, the sky turns a bit dimmer as the moon passes in front of the sun. Typically viewable by millions, a solar eclipse can be a magnificent spectacle, but the event should come with caution, experts say. 

Author Kara Mason | Publish Date October 12, 2023
Full Story

Patient Care    Drug Development    Retina    rare disease

CU Ophthalmologists Administer Novel Treatment for Single Patient Facing Rare Genetic Condition

Thirteen-year-old Grace Hoyt received potentially the best birthday gift ever this month when pediatric ophthalmologists at the University of Colorado School of Medicine and Children’s Hospital Colorado administered the first treatment designed specifically to slow her vision loss associated with posterior column ataxia with retinitis pigmentosa (PCARP), a rare genetic condition that affects vision and the nervous system.

Author Kara Mason | Publish Date September 06, 2023
Full Story

Patient Care    Awareness    Pediatric Cancer    Retina

From Beating Retinoblastoma to Batting with Big Leaguers

This summer, six-year-old Coleman Tawresey will go more than 12 consecutive weeks without a doctor’s appointment – something he hasn’t been able to do since being diagnosed with retinoblastoma when he was two.

Author Kara Mason | Publish Date August 07, 2023
Full Story

Research    Cornea    Retina    Diabetic retinopathy

Seeing the Opportunities of AI in Ophthalmology

The state of modern AI is really exciting for health care. With increasing computing capabilities and access to vast datasets, new algorithms are being developed every day. In that sense, the technology has arrived, but there are many remaining challenges in implementing AI in clinical settings.

Author Toni Lapp | Publish Date November 01, 2022
Full Story

Research    Age-Related Macular Degeneration (AMD)    Retina   

CellSight Surpasses Benchmarks Toward Making Retinal Transplants a Reality

Generating retinas from stem cells and transplant technologies to restore human sight felt like just a dream for Valeria Canto-Soler, PhD, associate professor of ophthalmology in the University of Colorado School of Medicine. When she joined the CU Department of Ophthalmology faculty in 2017, she signed on as the inaugural director of CellSight, the department’s ocular stem cell and regeneration research program, setting benchmarks 15 years in the future.

Author Rachel Wittel | Publish Date September 12, 2022
Full Story

Research    Retina    Awards   

CellSight Teams Clinch Top Two of Three Awards in National Eye Institute Competition

The University of Colorado Department of Ophthalmology’s ocular stem cell and regeneration research program, CellSight, was awarded the top two prizes in the National Eye Institute’s 3D Retinal Organoid Challenge (NEI 3D ROC). The NEI, part of the National Institutes of Health, launched the three-phase challenge in 2017 to stimulate research using retina organoids. These organoids are similar to human retinas but are grown in a lab from stem cells, enabling researchers to study eye diseases and treatments noninvasively.

Author Toni Lapp | Publish Date September 01, 2022
Full Story

Research    Neuro-Ophthalmology    Retina    Awards

ASPIRE Grant Awarded to Study Vision Loss Following Traumatic Brain Injury

A $200,000 grant from the University of Colorado School of Medicine's Program to Advance Physician Scientists and Translational Research (CU ASPIRE) will support researchers to develop new, targeted therapies for those who have experienced vision loss following traumatic brain injuries.

Author Toni Lapp | Publish Date August 24, 2022
Full Story

Patient Care    Pediatric Ophthalmology    Retina

First Telemedicine Service Launched in Colorado for Infants with Retinopathy of Prematurity

A new service in Colorado will strengthen care and comfort for infants with retinopathy of prematurity through a hybrid in-person and telemedicine approach. Many infants born prematurely face the risks of retinopathy of prematurity (ROP), a potentially blinding eye disease that occurs because blood vessels in the back of the eye are not fully developed and could grow abnormally after premature birth.

Author Rachel Wittel | Publish Date August 05, 2022
Full Story

See Us In the News


First patient at UCHealth receives new treatment for Alzheimer’s disease

news outletUCHealth
Publish DateJuly 03, 2024

Leqembi is not a cure for Alzheimer’s. But it’s the first FDA-approved drug that has shown evidence of slowing cognitive declines. UCHealth medical experts have now set up a safe system to screen patients and give infusions of Leqembi to those who qualify.

Full Story
Clinical Insights in Eyecare

Case Report: Neurotrophic Ulcer Secondary to a Hypoplastic Trigeminal Nerve in a Three-Year-Old Boy

news outletClinical Insights in Eyecare
Publish DateJuly 03, 2024

Kaleb Abbott, OD, MS, FAAO, Melissa Engle, OD, FAAO, and Emily McCourt, MD, present a challenging case of a boy aged 3 years with a refractory neurotrophic ulcer secondary to congenital trigeminal anesthesia treated with recombinant human nerve growth factor and corneal neurotization surgery.

Full Story
NBC News

How Art Therapy Is Alleviating Health Care Workers’ Burnout

news outletNBC News
Publish DateJuly 03, 2024

Research shows this Colorado program has helped lower anxiety, depression and PTSD among health professionals.

Full Story
American Academy of Ophthalmology

The Challenges of Vision Care in Alzheimer Disease Patients

news outletAmerican Academy of Ophthalmology
Publish DateJune 10, 2024

Victoria Pelak, MD, professor of ophthalmology and neurology at the University of Colorado School of Medicine, offers insights into how Alzheimer disease — and the drugs used to treat it — can affect eye health.

Full Story